WARNING

Tebentafusp is a novel immunotherapy drug used in the treatment of metastatic uveal melanoma, a rare and aggressive form of eye cancer. Please note that information about medications may have evolved since then, and it is crucial to consult with a healthcare professional or refer to the latest medical literature for the most up-to-date information.

Tebentafusp may have potential side effects and risks, including:

• Immune-related adverse events (irAEs): Tebentafusp works by activating the immune system, which can lead to immune-related side effects. These may include rash, diarrhea, fatigue, and liver enzyme abnormalities.
• Cytokine release syndrome (CRS): Like some other immunotherapies, Tebentafusp may trigger an excessive release of cytokines, leading to symptoms such as fever, chills, and flu-like symptoms.
• Autoimmune reactions: Activation of the immune system may cause it to attack healthy cells, leading to autoimmune reactions. This can result in a variety of symptoms depending on the affected organs.
• Infusion reactions: Some individuals may experience reactions during or after the infusion of Tebentafusp, including fever, chills, or allergic reactions.
• Cardiovascular events: There may be an increased risk of cardiovascular events, and patients may be monitored for signs of cardiac issues.

It’s crucial for individuals considering Tebentafusp or any other medication to have a thorough discussion with their healthcare provider about the potential risks, benefits, and side effects. The information provided here is a general overview and may not encompass all possible risks associated with Tebentafusp. Always refer to the latest prescribing information and consult with a healthcare professional for personalized advice.

Why is this medication prescribed?

Tebentafusp is prescribed for the treatment of metastatic uveal melanoma, a rare and aggressive form of eye cancer. Uveal melanoma originates in the eye’s uvea, which includes the iris, ciliary body, and choroid.

Tebentafusp is classified as an immunotherapy and works by stimulating the immune system to target and destroy cancer cells expressing a specific protein called gp100. This treatment aims to harness the body’s immune response to fight against cancer.

How should this medicine be used?

The usage of Tebentafusp injection is typically guided by healthcare professionals based on the specific circumstances of the patient and the latest medical guidelines. The following information provides a general overview of how Tebentafusp may be used. However, it’s crucial to note that specific details may vary, and the most accurate and up-to-date information can be obtained from healthcare providers or the latest prescribing information.

• Administration: Tebentafusp is administered intravenously (IV) in a healthcare setting. A qualified healthcare professional, such as a nurse or physician, typically administers the injection. The intravenous infusion may take a specific amount of time, and the duration can depend on the healthcare provider’s instructions.
• Dosage: The dosage of Tebentafusp is determined based on various factors, including the patient’s weight, overall health, and the specific treatment plan. The healthcare provider will calculate the appropriate dosage for each individual case.
• Treatment Schedule: The treatment with Tebentafusp often involves multiple cycles, and the specific schedule may vary. Healthcare providers will determine the appropriate timing and duration of treatment based on the patient’s response and overall health.
• Monitoring: Patients receiving Tebentafusp are usually monitored closely during and after the infusion to detect and manage any potential side effects or adverse reactions. Regular check-ups and follow-up appointments are integral to assessing the patient’s response to the treatment.

As guidelines and information may have evolved since last update, individuals considering or receiving Tebentafusp should consult with their healthcare provider for the most current and personalized information regarding the drug’s usage, dosage, and administration. Always follow the healthcare provider’s instructions and refer to the latest medical literature or prescribing information for comprehensive details.

Other uses for this medicine

Tebentafusp is primarily used for the treatment of metastatic uveal melanoma, and its approved indications may be limited to this specific condition. The information provided here is based on the knowledge available up to that point, and it’s important to note that new uses or indications may have emerged since then. Always consult with a healthcare professional or refer to the latest medical literature for the most up-to-date information.

What special precautions should I follow?

Regarding special precautions for Tebentafusp injection, it’s crucial to follow the guidance provided by healthcare providers. Here are general precautions that may be associated with Tebentafusp or similar immunotherapies:

• Monitoring: Patients may be closely monitored during and after Tebentafusp administration to detect and manage potential side effects or adverse reactions promptly.
• Immunotherapy-related adverse events: Tebentafusp may lead to immune-related adverse events (irAEs), which can affect various organs. Patients should promptly report any new or worsening symptoms to their healthcare provider.
• Infusion reactions: Infusion reactions, including fever, chills, or allergic reactions, may occur during or after the administration of Tebentafusp. Patients should inform healthcare providers of any discomfort or symptoms experienced during the infusion.
• Autoimmune reactions: Due to its mechanism of action in stimulating the immune system, Tebentafusp may cause autoimmune reactions. Patients should be monitored for signs of autoimmune disorders, and healthcare providers should manage such reactions accordingly.
• Cardiovascular monitoring: There may be an increased risk of cardiovascular events, and patients may undergo cardiovascular monitoring as part of the treatment plan.
• Pregnancy and breastfeeding: The safety of Tebentafusp during pregnancy and breastfeeding may not be well-established, and patients should discuss potential risks and benefits with their healthcare provider if they are pregnant or planning to become pregnant.

These precautions are general in nature, and specific recommendations may vary based on individual patient characteristics and the latest medical guidelines. Patients should communicate openly with their healthcare team, report any unusual symptoms, and attend regular follow-up appointments as advised by their healthcare provider. Always consult with a healthcare professional for personalized guidance based on the most current information available.

What special dietary instructions should I follow?

As of last update, there were no specific dietary instructions associated with Tebentafusp. However, it’s crucial to discuss any dietary concerns or restrictions with your healthcare provider. They can provide personalized advice based on your overall health and specific medical conditions.

What should I do if I forget a dose?

What side effects can this medication cause?

Tebentafusp injection, like any medication, may cause side effects. It’s important to note that not everyone will experience these side effects, and some individuals may experience different degrees of severity. Common side effects of Tebentafusp injection include:

• Infusion Reactions: These reactions can occur during or after the infusion and may include symptoms such as fever, chills, rash, itching, shortness of breath, and low blood pressure. These reactions are usually managed by adjusting the infusion rate or providing other appropriate medical interventions.
• Fatigue: Feeling tired or lethargic is a common side effect of Tebentafusp.
• Nausea: Some individuals may experience nausea or an upset stomach.
• Peripheral Edema: Swelling in the hands or feet may occur.
• Headache: Headaches are a reported side effect, though they are generally mild.
• Cough: Some people may develop a cough as a side effect of Tebentafusp.
• Vomiting: In some cases, individuals may experience vomiting.
• Joint Pain: Joint pain or discomfort may occur.

It’s essential to report any side effects to your healthcare provider promptly. Additionally, some side effects may not be listed here, and individual responses to the medication can vary. Serious or persistent side effects should be reported immediately. Your healthcare provider can provide guidance on managing side effects and may adjust your treatment plan if necessary.

This list is not exhaustive, and it’s crucial to consult with your healthcare provider or pharmacist for a comprehensive understanding of potential side effects based on your individual health condition and medical history.

What should I know about storage and disposal of this medication?

Storage and Disposal:

• Store Tebentafusp injections in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). Do not freeze.
• Keep the medication in its original packaging until ready for use to protect it from light.
• Do not shake the vial; gently swirl to mix if needed.
• Check the expiration date on the label and do not use the medication if it has expired.
• Dispose of any unused portion of the medication properly according to local regulations for hazardous waste disposal. Do not dispose of it in household trash.

In case of emergency/overdose

In case of an emergency or overdose with Tebentafusp injection, it is important to seek immediate medical attention. Symptoms of overdose may include severe infusion reactions or other adverse effects. Be prepared to provide information about the medication taken, the dose, and the time it was taken.

What other information should I know?

• Tebentafusp injection is administered intravenously (into the vein) by a healthcare professional in a clinical setting such as a hospital or infusion center.
• Before using Tebentafusp, inform your healthcare provider about any medical conditions you have, medications you are taking (including prescription, over-the-counter, vitamins, and herbal supplements), and any allergies you have.
• Monitor for signs of infusion reactions during and after administration, such as fever, chills, rash, itching, shortness of breath, or low blood pressure. These reactions may require immediate medical attention.
• Report any side effects or adverse reactions to your healthcare provider promptly.
• Follow all instructions provided by your healthcare provider for the safe and effective use of Tebentafusp injection.

Always consult with your healthcare provider or pharmacist for specific instructions and guidance regarding the storage, disposal, and management of Tebentafusp injection.